SCHEMBL23536012

SCHEMBL23536012

O=[N+]([O-])c1cccc(F)c1N1CCC(CN2CC3CC(C2)O3)CC1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.37
GAA P10253 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
KDM4E B2RXH2 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPT P10636 4/20 0.34
SIGMAR1 Q99720 1/20 0.34
LMNA P02545 1/20 0.34
HTT P42858 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPK1 P28482 1/20 0.34
GRM2 Q14416 1/20 0.34
GPR174 Q9BXC1 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29932075 1.00 ALDH1A1 (0.37) ALDH1A1GAACYP1A2CYP2C9CYP2C19
SCHEMBL29932007 0.88 ALDH1A1 (0.41) ALDH1A1GAACYP1A2CYP2C9CYP2C19
SCHEMBL29932012 0.88 ALDH1A1 (0.41) ALDH1A1GAACYP1A2CYP2C9CYP2C19
SCHEMBL23536079 0.88 ALDH1A1 (0.41) ALDH1A1GAACYP1A2CYP2C9CYP2C19
SCHEMBL23536056 0.88 ALDH1A1 (0.41) ALDH1A1GAACYP1A2CYP2C9CYP2C19
SCHEMBL23536073 0.81 BPTF (0.34) GRM2ACHE
SCHEMBL29932313 0.81 BPTF (0.34) GRM2ACHE
SCHEMBL23536259 0.80 ALDH1A1 (0.36) ALDH1A1GAACYP1A2CYP2C9CYP2C19
SCHEMBL29931820 0.80 ALDH1A1 (0.36) ALDH1A1GAACYP1A2CYP2C9CYP2C19
SCHEMBL23536366 0.78 ALDH1A1 (0.45) ALDH1A1GAACYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021127337-A1 TRPML MODULATORS CASMA THERAPEUTICS, INC. (US) 2021-06-24 WO disclosed